Page last updated: 2024-08-23

4-methoxyamphetamine and mycophenolic acid

4-methoxyamphetamine has been researched along with mycophenolic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrahams, AC; Hilbrands, LB; Hoitsma, AJ; Kho, MM; Sanders, JS; van den Hoogen, MW; van Dijk, M; van Zuilen, AD; Weimar, W1
Chen, J; Huang, H; Liu, G; Peng, W; Wu, J1

Trials

1 trial(s) available for 4-methoxyamphetamine and mycophenolic acid

ArticleYear
Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2013, Volume: 11, Issue:2

    Topics: Adult; Aged; Antilymphocyte Serum; Death; Delayed Graft Function; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; T-Lymphocytes; Tacrolimus; Tissue Donors; Transplantation, Homologous; Young Adult

2013

Other Studies

1 other study(ies) available for 4-methoxyamphetamine and mycophenolic acid

ArticleYear
Short-Term Intensified Dosage Regimen of Mycophenolic Acid is Associated with Less Acute Rejection in Kidney Transplantation from Donation after Circulatory Death.
    Urologia internationalis, 2018, Volume: 101, Issue:4

    Topics: Adult; Area Under Curve; Biopsy; China; Death; Delayed Graft Function; Drug Administration Schedule; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Patient Safety; Retrospective Studies; Tablets, Enteric-Coated; Tacrolimus; Treatment Outcome

2018